CRANBURY, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced that it will be presenting at the 2009 BIO Investor Forum on Thursday, October 29, 2009 at 8:30 AM PDT. Hosted by the Biotechnology Industry Organization (BIO), the 8th Annual BIO Investor Forum will take place October 28-29 at the Palace Hotel in San Francisco, CA.
Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com/. DATASOURCE: Palatin Technologies, Inc.
CONTACT: Investor Inquiries: Stephen T. Wills, CPA, MST, EVP-Operations, Chief Financial Officer, +1-609-495-2200, ; Media Inquiries: Susan Neath, Burns McClellan, Vice President, Investor Relations, +1-212-213-0006, Web Site: http://www.palatin.com/
|